Two-year outcome after Xpert stent implantation for treating below the knee lesions in critical limb ischemia

Vascular

Volumn 17, Issue 1, 2009, Pages 1-8

  Bosiers, Marc ^a   Lioupis, Christos ^a   Deloose, Koen ^a   Verbist, Jürgen ^b   Peeters, Patrick ^b  

^a AZ St Blasius ^*  (Belgium)

^b IMELDA HOSPITAL   (Belgium)

Author keywords

Below the knee; Critical limb ischemia; Limb salvage; Nitinol; Revascularization; Stent

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; NADROPARIN; NITINOL; ALLOY;

AGED; ARTICLE; FEMALE; HUMAN; KNEE INJURY; LIMB ISCHEMIA; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SATISFACTION; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; SCORING SYSTEM; STENT; THROMBOSIS PREVENTION; VASCULAR PATENCY; BLOOD VESSEL TRANSPLANTATION; CLINICAL TRIAL; DOPPLER ECHOGRAPHY; ECHOGRAPHY; EQUIPMENT DESIGN; FOLLOW UP; ISCHEMIA; KAPLAN MEIER METHOD; LEG; METHODOLOGY; MULTICENTER STUDY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RADIOGRAPHY; TREATMENT OUTCOME; VASCULARIZATION;

AGED; ALLOYS; BLOOD VESSEL PROSTHESIS IMPLANTATION; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISCHEMIA; KAPLAN-MEIERS ESTIMATE; LEG; LIMB SALVAGE; MALE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASCULAR PATENCY;

EID: 65549120792     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.2310/6670.2009.00002     Document Type: Article

References (32)

1. Horvath W, Oertl M, Haidinger D. Percutaneous transluminal angioplasty of crural arteries. Radiology 1990;177:565-9.
2. Dorros G, Jaff MR, Dorros AM, et al. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up. Circulation 2001;104:2057-62.
3. Bosiers M, Hart JP, Deloose K, et al. Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures. Vascular 2006;14:63-9.
4. Hanna GP, Fujise K, Kjellgren O, et al. Infrapopliteal transcatheter interventions for limb salvage in diabetic patients: importance of aggressive interventional approach and role of transcutaneous oximetry. J Am Coll Cardiol 1997;30:664-9.
5. Rand T, Basile A, Cejna M, et al. PTA versus carbofilm-coated stents in infrapopliteal arteries: pilot study. Cardiovasc Intervent Radiol 2006;29:29-38.
6. Parsons RE, Suggs WD, Lee JJ, et al. Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: do the results justify an attempt before bypass grafting? J Vasc Surg 1998; 28:1066-71.
7. Haider SN, Kavanagh EG, Forlee M, et al. Two-year outcome with preferential use of infrainguinal angioplasty for critical ischemia. J Vasc Surg 2006;43:504-12.
8. Kickuth R, Keo HH, Triller J, et al. Initial clinical experience with the 4-F self-expanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia. J Vasc Interv Radiol 2007;18:703-8.
9. Tepe G, Zeller T, Heller S, et al. Self-expanding nitinol stents for treatment of infragenicular arteries following unsuccessful balloon angioplasty. Eur Radiol 2007;17:2088-95.
10. Bosiers M, Deloose K, Verbist J, Peeters P. Nitinol stenting for treatment of "below-the-knee" critical limb ischemia: 1-year angiographic outcome after Xpert stent implantation. J Cardiovasc Surg (Torino) 2007;48:455-61.
11. Sacks D, Marinelli DL, Martin LG, Spies JB. Reporting standards for clinical evaluation of new peripheral arterial revascularization devices. J Vasc Interv Radiol 2003;14(9 Pt 2):S395-404.
12. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45 Suppl S:S5-67.
13. Kalra M, Gloviczki P, Bower TC, et al. Limb salvage after successful pedal bypass grafting is associated with improved long-term survival. J Vasc Surg 2001;33:6-16.
14. Adam DJ, Beard JD, Cleveland T, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL): multicentre, randomised controlled trial. Lancet 2005;366:1925-34.
15. Tefera G, Hoch J, Turnipseed WD. Limb-salvage angioplasty in vascular surgery practice. J Vasc Surg 2005;41:988-93.
16. Clair DG, Dayal R, Faries PL, et al. Tibial angioplasty as an alternative strategy in patients with limb-threatening ischemia. Ann Vasc Surg 2005;19:63-8.
17. Feiring AJ, Wesolowski AA, Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes. J Am Coll Cardiol 2004;44:2307-14.
18. Dorros G, Jaff MR, Murphy KJ, Mathiak L. The acute outcome of tibioperoneal vessel angioplasty in 417 cases with claudication and critical limb ischemia. Cathet Cardiovasc Diagn 1998;45:251-6.
19. Albers M, Romiti M, Brochado-Neto FC, et al. Meta-analysis of popliteal-to-distal vein bypass grafts for critical ischemia. J Vasc Surg 2006;43:498-503.
20. Soder HK, Manninen HI, Jaakkola P, et al. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results. J Vasc Interv Radiol 2000;11: 1021-31.
21. Boyer L, Therre T, Garcier JM, et al. Infrapopliteal percutaneous transluminal angioplasty for limb salvage. Acta Radiol 2000;41: 73-7.
22. Kraitzer A, Kloog Y, Zilberman M. Approaches for prevention of restenosis. J Biomed Mater Res B Appl Biomater 2007;85B: 583-603.
23. Schwarzmaier-D'Assie A, Karnik R, Bonner G, et al. Fracture of a drug-eluting stent in the tibioperoneal trunk following bifurcation stenting. J Endovasc Ther 2007;14:106-9.
24. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45:312-5.
25. Bosiers M, Kallakuri S, Deloose K, et al. Infragenicular angioplasty and stenting in the management of critical limb ischaemia: one year outcome following the use of the MULTI-LINK VISION stent. Eurointervention 2007;3:470-4.
26. Scheinert D, Ulrich M, Scheinert S, et al. Comparison of sirolimuseluting vs. bare-metal stents for the treatment of infrapopliteal obstructions. Eurointervention 2006;2:169-74.
27. Siablis D, Karnabatidis D, Katsanos K, et al. Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefit. J Endovasc Ther 2007;14: 241-50.
28. Sabeti S, Schillinger M, Amighi J, et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology 2004;232:516-21.
29. Hoffmann R, Mintz GS, Haager PK, et al. Relation of stent design and stent surface material to subsequent in-stent intimal hyperplasia in coronary arteries determined by intravascular ultrasound. Am J Cardiol 2002;89:1360-4.
30. Commeau P, Barragan P, Roquebert PO. Sirolimus for below the knee lesions: mid-term results of SiroBTK study. Catheter Cardiovasc Interv 2006;68:793-8.
31. Siablis D, Kraniotis P, Karnabatidis D, et al. Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J Endovasc Ther 2005;12:685-95.
32. Bosiers M, Deloose K, Verbist J, Peeters P. Percutaneous transluminal angioplasty for treatment of "below-the-knee" critical limb ischemia: early outcomes following the use of sirolimus-eluting stents. J Cardiovasc Surg (Torino) 2006;47: 171-6.